Fish Consumption Linked to Lower Multiple Sclerosis Risk

Many studies suggest that certain dietary interventions may reduce the risk of multiple sclerosis (MS) or improve symptoms. The Mediterranean diet in particular has garnered significant attention for MS. The diet, which is rich in fish and vegetables, has been shown to reduce inflammation in patients with MS.
 
Related Coverage: New Study Explores Potential of Mediterranean Diet in Multiple Sclerosis
 
Novel study findings suggest that eating fish 1 to 3 times per month plus daily fish oil supplements may reduce MS risk. These results suggest that omega-3 fatty acids could lower the risk of developing MS, according to a press release.
 
The preliminary study will be presented at the American Academy of Neurology’s 70th Annual Meeting in April.
 
“Consuming fish that contain omega-3 fatty acids has been shown to have a variety of health benefits, so we wanted to see if this simple lifestyle modification, regularly eating fish and taking fish oil supplements, could reduce the risk of MS,” said study author Annette Langer-Gould, MD, PhD.
 
Included in the study were 1153 individuals of varying backgrounds who were an average age of 36. Approximately half of the patients were diagnosed with MS or clinically isolated syndrome (ICS). 
 
Data about diet and fish intake were gathered for each participant. The researchers characterized high fish intake as eating 1 serving of fish per week or 1 to 3 servings per month plus taking daily fish oil supplements, according to the release. Low fish intake was characterized as eating less than 1 serving of fish per month and no supplements. 
 
A total of 180 patients with MS and 251 healthy controls were found to have high fish intake, including consumption of shrimp, salmon, and tuna.
 
The authors discovered that patients with high fish consumption had a 45% reduced risk of MS or ICS compared with those who had low fish intake, according to the release.
 
The researchers also examined 13 variations in the human gene cluster that regulates fatty acids and discovered 2 that may lower MS risk, according to the study. These genes were found to reduce the risk of MS even after accounting for increased fish intake.
 
This finding may indicate that some individuals have an advantage in processing fatty acids, which could also modulate MS risk, according to the release.
 
Although the study findings suggest omega-3s are possibly involved with MS, the authors caution that it does not demonstrate a cause and effect relationship, but rather an association.
 
Additional studies are needed to confirm the results and determine how omega-3 fatty acids could impact inflammation, metabolism, and nerve function, which are all important factors for MS, according to the release. 


Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Health care providers managing patients with MS should remain cognizant of the link between unhealthy lifestyle behaviors and depression risks.
The FDA advises health care providers to counsel patients receiving alemtuzumab on symptoms related to stroke and arterial dissection.
Stopping treatment with fingolimod (Gilenya) can cause the disease to become much worse than before the medicine was started or while it was being taken, FDA officials warned.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$